EUVIMEDEUVIMED entdecken
Crossref

Enhancing the Susceptibility of Methicillin‐Resistant Staphylococcus aureus to β‐Lactam Antibiotics Through the Use of 4‐Methoxysalicyl Aldehyde

Jian Zhang, Jiayu Hou, Heng Wang, Lanqiao Wang, Xinyue He, Liping Sun, Minhe Cui, Jianfeng Wang, Peng Zhang iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202501828r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Jian Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Aldehydes, Staphylococcal Infections, Anti-Bacterial Agents. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Special Project for Medical and Sanitary Talent of Jilin Province, Health Science and Technology Capacity Enhancement Program of Jilin Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of β‐lactamase‐producing bacteria remains a significant public health threat. Their rapid proliferation across various environments has led to a marked decline in the clinical effectiveness of β‐lactam antibiotics against these resistant strains. Targeting β‐lactamase activity offers a promising approach to managing resistant bacteria, especially methicillin‐resistant Staphylococcus aureus (MRSA). Studies on in vitro MIC killing curves, β‐lactamase activity assays, and quantitative real‐time PCR of related β‐lactamase genes demonstrate that 4‐methoxy salicyl aldehyde (HMB) unveiled its ability to significantly boost the potency of various β‐lactam antibiotics against the S. aureus USA300 strain. Additionally, the study provided compelling evidence that HMB not only inhibits β‐lactamase activity but also amplifies the intracellular accumulation of reactive oxygen species within MRSA, thereby contributing to its heightened susceptibility to these antibiotics. It concurrently impacted both biofilm formation and the expression of related genes in MRSA. This dual mechanism of action underscores HMB's potential as a valuable adjunct in the treatment of β‐lactamase‐producing resistant bacteria. The combination of HMB and cefixime effectively protected host cells from MRSA‐induced damage in a co‐culture system. In vivo experiments confirmed that the synergistic treatment effectively controlled S. aureus infections, which therapeutic strategy increased survival rates, reduced bacterial colonization, inflammation, and tissue damage in the pneumonia mouse model. Additionally, HMB significantly accelerated skin wound healing in those infected with S. aureus USA300. These findings identify HMB as a novel β‐lactamase inhibitor with the potential to combat β‐lactamase‐producing bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusAldehydesStaphylococcal InfectionsAnti-Bacterial AgentsAnimalsbeta Lactam AntibioticsMiceMicrobial Sensitivity TestsBiofilmsbeta-LactamasesHumansReactive Oxygen SpeciesThird Generation CephalosporinsDrug Synergism

Stichwörter der Autor:innen

4‐methoxysalicyl aldehydeS. aureus USA300biofilmcefiximecell membraneβ‐Lactamase inhibitors

Substanzen

Aldehydesbeta Lactam AntibioticsAnti-Bacterial Agentsbeta-LactamasesReactive Oxygen SpeciesThird Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, China.
  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
  • School of Medicine and Health, Harbin Institute of Technology, Harbin, China.
  • Children's Diagnosis and Treatment Center, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • Jilin Mushuo Breeding Co., Ltd, Changchun, Jilin, China.

ORCID-Profile: Peng Zhang

Förderung

  • National Natural Science Foundation of China (NSFC)
  • Special Project for Medical and Sanitary Talent of Jilin Province
  • Health Science and Technology Capacity Enhancement Program of Jilin Provincial Health Commission
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhang, J., Hou, J., Wang, H., Wang, L., He, X., Sun, L., Cui, M., Wang, J., & Zhang, P. (2026). Enhancing the Susceptibility of Methicillin‐Resistant Staphylococcus aureus to β‐Lactam Antibiotics Through the Use of 4‐Methoxysalicyl Aldehyde. The FASEB Journal. https://doi.org/10.1096/fj.202501828r

Vancouver

Zhang J, Hou J, Wang H, Wang L, He X, Sun L, et al. Enhancing the Susceptibility of Methicillin‐Resistant Staphylococcus aureus to β‐Lactam Antibiotics Through the Use of 4‐Methoxysalicyl Aldehyde. The FASEB Journal. 2026. doi:10.1096/fj.202501828r

BibTeX
@article{Zhang2026,
  author = {Zhang, Jian and Hou, Jiayu and Wang, Heng and Wang, Lanqiao and He, Xinyue and Sun, Liping and Cui, Minhe and Wang, Jianfeng and Zhang, Peng},
  title = {Enhancing the Susceptibility of Methicillin‐Resistant Staphylococcus aureus to β‐Lactam Antibiotics Through the Use of 4‐Methoxysalicyl Aldehyde},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202501828r}
}
Kostenlos starten →